
|Videos|January 14, 2022
Global Society of Rare Genitourinary Tumors launches during pandemic
Author(s)Urology Times staff
“I really foresee this becoming a very critical society in this area for many, many years to come,” says Philippe E. Spiess, MD, MS, FRCSC, FACS.
Advertisement
In this video, Philippe E. Spiess, MD, MS, FRCSC, FACS, and Andrea Necchi, MD, discuss what is unique about the new Global Society of Rare Genitourinary Tumors, for which they serve as President and Vice President. Spiess is a genitourinary oncologist and assistant chief of surgical services at the Moffitt Cancer Center in Tampa, Florida. Necchi is an associate professor at Vita-Salute Raffaele University and the head of genitourinary medical oncology at IRCCS San Raffaele Hospital and Scientific Institute in Milan, Italy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA updates in urology: May 2026
4
FDA approves cefepime and zidebactam for complicated UTI
5











